New Hampshire Cannabis
Market Intelligence Report

New Hampshire's Therapeutic Cannabis Program reached 16,846 certified patients and caregivers as of June 2025, after adding more than 2,100 new registrants over the prior year — a roughly 14.5% increase and the program's fastest growth pace since 2021. The program is served by just 7 dispensary locations (Alternative Treatment Centers) operated by 3 vertically integrated nonprofit producers: GraniteLeaf Cannabis, Sanctuary Medicinals, and Temescal Wellness.

New Hampshire has no general state sales tax, and cannabis sold through the TCP is specifically exempted from the state's Meals & Rooms tax that would otherwise apply — meaning the program currently generates no direct state cannabis tax revenue. A specific dollar figure for total program sales was not identified in public state reporting reviewed for this report. (Not Available — total program sales revenue.)

New Hampshire's population of just under 1.4 million has one of the highest median household incomes in this report set, alongside one of the oldest median ages — both relevant to therapeutic cannabis program demand patterns. (Official, Census ACS 2024)

New Hampshire's Therapeutic Cannabis Program is regulated by the Department of Health and Human Services, with oversight from the Therapeutic Cannabis Medical Oversight Board. The program operates on a not-for-profit, vertically integrated model: 3 licensed Alternative Treatment Center producers handle cultivation, production, and dispensing across 7 statewide locations — there is no separate cultivator, processor, or for-profit retailer license tier as exists in most other states in this report set. Legislative changes in 2024 expanded patient qualifying conditions, contributing to the program's accelerated 2025 growth.

New Hampshire's not-for-profit ATC model itself functions as the program's defining structural feature rather than a tax incentive: ATCs are statutorily required to be nonprofit entities, and TCP sales are exempt from the Meals & Rooms tax that would otherwise apply.

New Hampshire's supply chain is the most vertically concentrated of any state in this report set: all cultivation, processing, and dispensing occurs within just 3 nonprofit ATC operators, with no independent cultivator or processor license tier. This structure limits third-party vendor opportunities largely to ancillary services and equipment rather than wholesale product supply relationships.

Patient registry growth, the clearest available demand indicator, accelerated to its fastest pace since 2021 following 2024's qualifying-condition expansion. Total program sales revenue figures were not identified in public state reporting reviewed for this report. (Not Available — total sales revenue.)

New Hampshire's 7 ATC locations are spread across the state in Chichester, Conway, Dover, Keene, Lebanon, Merrimack, and Plymouth, providing geographic coverage from the Seacoast to the North Country. The Department of Health and Human Services does not publish a county-by-county sales or patient breakdown. (Not Available — county-level breakdown.)

With no open licensing window and only 3 existing nonprofit ATC operators, New Hampshire's cost-to-enter dynamics differ structurally from for-profit medical or adult-use markets.

Vendor demand signal tracks which product and service categories New Hampshire's 3 ATC operators are actively sourcing this quarter.

New Hampshire has no general state sales tax, and therapeutic cannabis sales are specifically exempt from the Meals & Rooms tax that would otherwise apply — meaning the program generates no direct state cannabis tax revenue under current law. A legislative fiscal estimate has projected the state could collect approximately $37 million annually if it legalized and taxed adult-use cannabis sales; this is a projection of potential future revenue, not current TCP activity, and is labeled accordingly.

New Hampshire is now the only one of its three immediate U.S. state neighbors without adult-use legalization — a distinctive regional position among the states in this report set.

New Hampshire does not publish a consolidated statewide cannabis-industry employment figure. With only 3 vertically integrated nonprofit operators across 7 locations, direct industry employment is almost certainly among the smallest of any state in this report set, though no official total is available. (Not Available.)

New Hampshire's Therapeutic Cannabis Program does not include a dedicated social equity license track; the program's not-for-profit, fixed 3-operator structure has limited new-entrant opportunities of any kind since the program's launch. (Official.)

New Hampshire does not publish an official illicit cannabis market size estimate. With cannabis remaining illegal for non-patient adult use, and the state bordered by three adult-use neighbors with materially lower-friction legal access, cross-border purchasing and an unregulated in-state market likely both exist, though no official dollar figure quantifies either. (Not Available.)

This report blends official New Hampshire DHHS patient registry and ATC licensing data, Department of Revenue Administration tax guidance, legislative fiscal estimates (clearly labeled as projections), and federal demographic sources.

This report compiles data from the New Hampshire Department of Health and Human Services, the Department of Revenue Administration, state legislative records, federal demographic sources, and reputable cannabis policy media.